Mark David Novara sold $46 of TNDM
EVP & CHIEF COMMERCIAL OFFICER at TANDEM DIABETES CARE INC. 2 shares at an average of $22.81, traded Mar 5, 2026, filed Mar 9, 2026.
Score components
- +15RoleOfficer
- 0Trade size$46 at market
- 0Share of holdings soldSold 0.0% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -7.3%, 3m -11.5%, 6m -4.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001438133-26-000022, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | SOpen-market sale Common Stock10b5-1 | -2 | $22.81 | $46 | 35,969 | Mar 9, 2026 |
Related signals
Other insiders at TANDEM DIABETES CARE INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | TANDEM DIABETES CARE INC | Mark David Novara EVP & CHIEF COMMERCIAL OFFICER | $4,310 187 shares | -0% | |
| 64Notable | TANDEM DIABETES CARE INC | John F Sheridan PRESIDENT & CEO | $102k 10,000 shares | +10% | |
| 69Notable | TANDEM DIABETES CARE INC | Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER | $149k 13,720 shares | +116% | |
| 40Moderate | TNDMbuy TANDEM DIABETES CARE INC | Jean-Claude Kyrillos EVP & Chief Operating Officer | $191k 10,538 shares | - | |
| 45Moderate | TNDMsell TANDEM DIABETES CARE INC | Kim D Blickenstaff director | $1.2M 40,000 shares | -19% | |
| 23Weak | TNDMbuy TANDEM DIABETES CARE INC | Mark David Novara EVP & CHIEF COMMERCIAL OFFICER | $12k 532 shares | - | |
| 39Weak | TNDMbuy TANDEM DIABETES CARE INC | Dick Allen director | $95k 5,000 shares | +33% | |
| 54Moderate | TANDEM DIABETES CARE INC | Shannon Marie Hansen Chief Legal Officer | $30k 1,935 shares | - | |
| 68Notable | TANDEM DIABETES CARE INC | Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER | $95k 6,200 shares | +110% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.